Syringic acid alleviates cadmium-induced neurotoxicity in rats by modulating cellular signaling pathways

ArticleAçık Erişim

Özet

Cadmium (Cd) is a metal found widely in nature that negatively affects brain health by affecting the DNA repair mechanisms of the cell through the effect it creates on various reactive oxygen species in the body. Antioxidants provide the potential to reduce the neurotoxic effects of cadmium. Therefore, we aimed to investigate the protective properties of syringic acid (SA) in cadmium-induced neurotoxicity. Fifty male Sprague Dawley rats were used in the study. The rats were divided into 5 groups: Control, SA100, Cd, SA50 + Cd and SA100 + Cd. Cd (6.5 mg/kg) was administered intraperitoneally, and SA (50–100 mg/kg) intragastrically for seven days. Our results showed that SA significantly mitigated Cd-induced brain damage. The up-regulation of MDA and down-regulation of GSH, SOD, and CAT in brain tissues induced by Cd was significantly reversed by SA treatment. Additionally, the decreased expression of Nrf2/HO-1/SIRT1, impaired by ROS induced by Cd, was enhanced by SA. While Cd caused inflammation by triggering proinflammatory cytokines such as IL-1β and TNF-α via TLR4/NF-κB and suppressing IL-10, SA reduced inflammation in the tissue. This study demonstrated that SA treatment significantly reversed Beclin-1 and LC3A/B expression. Finally, it was revealed that SA treatment inhibited Cd-induced apoptosis by decreasing Bax, Caspase3 levels, and increasing Bcl2 levels. Collectively, our data revealed that SA exerts its neuroprotective effects by regulating various Cd-induced cellular signaling pathways in rat brains. © 2024

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10922Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBolat, Merve
dc.contributor.authorYilmaz, Tuğçe Ertek
dc.contributor.authorÇeğindir, Murat
dc.contributor.authorAtasever, Aslıhan
dc.contributor.authorDoğan, Tuba
dc.contributor.authorYildirim, Serkan
dc.contributor.authorSağlam, Yavuz Selim
dc.contributor.authorÇomakli, Selim
dc.contributor.authorBolat, İsmail
dc.date.accessioned2026-10-18T20:26:02.116877759Z
dc.date.available2026-10-18T20:26:02.116877759Z
dc.date.issued2025
dc.description.abstractCadmium (Cd) is a metal found widely in nature that negatively affects brain health by affecting the DNA repair mechanisms of the cell through the effect it creates on various reactive oxygen species in the body. Antioxidants provide the potential to reduce the neurotoxic effects of cadmium. Therefore, we aimed to investigate the protective properties of syringic acid (SA) in cadmium-induced neurotoxicity. Fifty male Sprague Dawley rats were used in the study. The rats were divided into 5 groups: Control, SA100, Cd, SA50 + Cd and SA100 + Cd. Cd (6.5 mg/kg) was administered intraperitoneally, and SA (50–100 mg/kg) intragastrically for seven days. Our results showed that SA significantly mitigated Cd-induced brain damage. The up-regulation of MDA and down-regulation of GSH, SOD, and CAT in brain tissues induced by Cd was significantly reversed by SA treatment. Additionally, the decreased expression of Nrf2/HO-1/SIRT1, impaired by ROS induced by Cd, was enhanced by SA. While Cd caused inflammation by triggering proinflammatory cytokines such as IL-1β and TNF-α via TLR4/NF-κB and suppressing IL-10, SA reduced inflammation in the tissue. This study demonstrated that SA treatment significantly reversed Beclin-1 and LC3A/B expression. Finally, it was revealed that SA treatment inhibited Cd-induced apoptosis by decreasing Bax, Caspase3 levels, and increasing Bcl2 levels. Collectively, our data revealed that SA exerts its neuroprotective effects by regulating various Cd-induced cellular signaling pathways in rat brains. © 2024
dc.identifier.doi10.1016/j.intimp.2025.114816
dc.identifier.eissn1878-1705
dc.identifier.issn1567-5769
dc.identifier.pmid40354709
dc.identifier.scopus2-s2.0-105004582473
dc.identifier.startpage114816
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10922
dc.identifier.volume158
dc.identifier.wosWOS:001491133400001
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Immunopharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectApoptosis
dc.subjectBrain
dc.subjectCadmium
dc.subjectInflammation
dc.subjectOxidative stress
dc.subjectSyringic acid
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectCytokines
dc.subjectGallic Acid
dc.subjectHeme Oxygenase (Decyclizing)
dc.subjectMale
dc.subjectNeuroprotective Agents
dc.subjectNeurotoxicity Syndromes
dc.subjectNF-E2-Related Factor 2
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.subjectReactive Oxygen Species
dc.subjectSignal Transduction
dc.subjectSirtuin 1
dc.subjectbeclin 1
dc.subjectinterleukin 10
dc.subjectinterleukin 1beta
dc.subjecttoll like receptor 4
dc.subjecttumor necrosis factor
dc.subjectantioxidant
dc.subjectcytokine
dc.subjectheme oxygenase
dc.subjectHmox1 protein, rat
dc.subjectneuroprotective agent
dc.titleSyringic acid alleviates cadmium-induced neurotoxicity in rats by modulating cellular signaling pathways
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus18
rdl.citation.wos17
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)